CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment options for patients with advanced liver disease
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment options for patients with advanced liver disease
Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement marks the planned reintroduction of the minimally invasive technology to clinicians and patients following a period of limited market availability. The Ellipsys System, previously available...
Inaugural case performed by spine surgeon Dr. Scott L. Parker highlights the system's strength, versatility, and precision for supporting multi-level spinal constructs
On March 12, 2026, the first implant of the ProStyle M® Transcatheter Mitral Valve System (ProStyle M®) was successfully completed under pure ultrasound guidance as part of its confirmatory clinical study. The device is independently developed by KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). The procedure was performed by Professor Wang Chunsheng and Professor...
Company Appoints D. Keith Grossman to Board of Directors
Mechanism-Driven Study Design Focused on Capital Efficiency and Accelerated Development for Near-Term Value Creation, Addressing a $2 Billion Potential Target Market
Variational AI introduces Enki™ 4: an improved algorithm and architecture designed to scale, expanding the pre-trained target coverage from 592 to 760 and now applicable to proximity-based therapeutics and novel payloads for antibody drug conjugates
Akira Kitamura, GM, AI Drug Development Division of NEC Corporation and CEO of NEC Bio, added, "This agreement is an important milestone in our partnership with Transgene and reflects NEC’s long-term commitment to the development of TG4050
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
This strategic move unites Fertio’s 20+ years of global expertise with Cascade’s innovative early donor disclosure program, advancing fertility care and family-building options for U.S. parents
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’

Transaction will expand VB Spine’s enhanced visualization portfolio to include augmented reality navigation with the Augmedics xvision Spine System®

The VitalsBridge products are acquired from Dynasthetics, based in Salt Lake City, Utah. The company is well known for creating and producing simulation, anaesthesia, and respiratory products.
The funding will accelerate Earendil Labs’ AI-driven R&D platform, expand its interdisciplinary teams, and advance a growing pipeline of antibody and biologics programs, with the goal of delivering first-in-class and best-in-class therapies for patients with serious diseases.
Financing co-led by Taiho Ventures and Arkin Bio Capital with significant participation from other new and existing investors

Pharmacovigilance has traditionally required organizations to balance the urgency of reporting with the rigor of accurately detecting adverse event and product complaints. AI has the potential to ease this burden by enabling earlier pre‑signal identification, automated detection, faster case processing and expanded surveillance across both structured and unstructured data
By Dinesh Kumar, Ph.D., Founder and CEO of Blend Health Technologies

The CellTolerance® Test ends years of trial-and-error diets by pinpointing food intolerances through live cellular imaging
With these latest clearances, Restore Robotics continues to deliver on its mission to provide hospitals and surgery centers with cost-effective, high-quality, and sustainable alternatives to purchasing new robotic instruments from original equipment manufacturers.
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfunction

Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership.
Dr. Lee is a renowned talent, in the fields of both neurosurgery and finance
In her role with Metacarpal, Richer will focus on clinical education and support, helping prosthetists, therapists, and care teams understand where the Metacarpal GEM can fit within care pathways and how to optimize outcomes for appropriate patients

Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care

By simplifying complex cardiac anatomy through real-time AI labeling, T-Mode™ Heart removes the training barrier to ultrasound adoption for family physicians and medical students

Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows
Chief People Officer, Nikki Romence, has been named one of Becker’s Hospital Review’s “140 Hospital and Health System CHROs and Chief People Officers to Know” for 2026
Located in southeast Jacksonville near Baptist Medical Center Clay, the multispecialty ASC supports procedures in orthopedics, urology, otolaryngology, pain management, and general surgery. With 15 physician partners committed to the center, the partnership is evaluating expansion opportunities to meet growing demand.
The clinic is currently conducting research into single-fraction treatment, where therapy is delivered in one session (while traditional radiotherapy requires 20–40 treatment sessions)
For the study, 564 U.S. Special Operations Forces personnel (mean age 43 years, 563 men) were evaluated in the Comprehensive Brain Health and Trauma Program.
Teams delivering minimally invasive care face radiation exposure and orthopedic injuries that could be reduced through new policies and modern technology
The research focused on patients with stage T1a renal cell carcinoma, a cancer that is increasingly found incidentally on CT scans performed for other reasons, such as imaging of the prostate or ovaries
Equipping these frontline workers with comprehensive first aid and CPR in Ottawa ensures that every clinic operates with a seamless, highly prepared safety protocol from the very moment a patient walks through the front door.

Creating a healthier indoor workplace is not a single project — it is an ongoing commitment to the people who spend their working hours inside your building.

Swypes is calling attention to a critical gap in healthcare hygiene: although hospitals and nursing homes enforce strict infection-control protocols, CDC figures and published research suggest mobile phones remain an overlooked risk in daily care settings, with one meta-analysis finding contamination on 84.5% of healthcare workers’ devices

Choosing the right partner to build a digital health product is a high-stakes decision that goes far beyond checking boxes on a list of technical requirements
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.